The Academia-Industry Training (AIT) India program is designed to help young researchers and founders of science-based Swiss startups identify the commercial potential of their innovations while developing key entrepreneurial skills. The program - organized by Venturelab and supported by Leading House South Asia and Iran at ZHAW Zurich University of Applied Sciences and Swissnex India - includes a week-long trip to India in November and a follow-up session in Switzerland in February 2025, facilitating exchanges between two dynamic innovation ecosystems.
In support of Swiss entrepreneurs' aspirations, the Swiss State Secretariat for Education, Research and Innovation (SERI) has entrusted the execution of the AIT program to the Leading House in South Asia and Iran at ZHAW. This collaborative initiative is strengthened by partnerships with Venturelab and Swissnex India, the prominent business Embassy of Switzerland in India, recognized for its focus on building business networks with the highest professional standards.
"I learned and saw India up close thanks to the AIT India program. India is a huge market with big opportunities. I got to experience the support presented for Indian startups and startups that want to expand to India," highlighted Timur Ashirov, CEO of Separatic. "Every startup looking for opportunities in Asia should apply for this program."

"AIT was truly a full immersion into India and its incredible startup ecosystem. For a young startup like SaisiR, pitching at the Bengaluru Tech Summit was unbeatable. The program's mix of workshops and visits, like the Mazumdar Shaw Medical Foundation, introduced me to experienced innovators in stroke rehabilitation. Sharing this journey with fellow sciencepreneurs from Switzerland and India was a highlight, building connections I believe will last," added Claudia Bigoni, founder of SaisiR.



AZURECELL SA: Engineering Hope. Restoring the brain. One cell at a time.
AzureCell is a Swiss regenerative cell therapy company born from two decades of pioneering neuroscience and cell-engineering research at the University of Geneva. We are scientists and innovators u... Read more
BCellOne: We democratize cell therapies using nanotechnology
BCellOne addresses a key problem in cell and gene therapy: the high cost, safety risks, and inefficiencies of traditional viral vectors and standard electroporation methods, which can cause significan... Read more
Brightank SA: Ammonia catalyst for cleaner energy.
As demand for renewable energy continues to grow, meeting this demand in remote or mobile settings remains challenging. Current solutions, such as batteries, often fall short in supporting heavy indus... Read more
Impli AG: Impli is developing a hormone monitoring implant for IVF
Impli is a biotech company working on subdermal hormone monitoring platforms. The first product identified for market launch as a medical device in 2027 in the U.S. will be for women undergoing IVF... Read more
Inveel GmbH: High-resolution printed robotic skin.
Inveel specializes in the development of high-resolution sensory skins that provide robots with a sense of touch. They have innovated a groundbreaking technology that integrates nanometer-precise sens... Read more
Onescope SA: Digital stethoscope powered by AI for automated diagnosis.
OneScope SA is developing a unique autonomous multi-parameter stethoscope called Pneumoscope using artificial intelligence (AI) for lung sounds classification, disease severity grading, and clinical o... Read more
Phorest: Manufacturing pharma ingredients from renewable feedstock.
The project aims to bring about a transformation for pharmaceutical, agrochemical and flavors/fragrances production by replacing petroleum-based feedstocks with widespread and currently underutilized ... Read more
SaisiR: Neurotechnologies to help patients regain independence.
Stroke is a major cause of disability worldwide, leaving 25 million people with severe impairments and unable to perform activities of daily living. SaisiR introduces a revolutionary therapy based on ... Read more
SEPARATIC Sarl: Porous graphene membranes for efficient CO2 capture
SEPARATIC is a Swiss deep-tech startup disrupting the carbon capture industry through its patent-pending Porous Graphene Membranes (PGM), which utilize a "templated plasma etching" breakthrough to cre... Read more